Loading clinical trials...
Loading clinical trials...
In Clinic Evaluation of the FreeStyle Navigator® Continuous Glucose Monitoring System Version 1.5
The purpose of the study is to confirm that the accuracy and safety of Version 1.5 of the FreeStyle Navigator Continuous Glucose Monitoring System are not impacted by the updates to the system algorithm and minor changes to the user interface and sensor delivery unit, such as adhesive sterilization method. It is anticipated that information collected will be submitted as a supplement to Premarket Approval Application (P050020) to the US Food and Drug Administration for approval to market this version of the system.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Diablo Clinical Research
Walnut Creek, California, United States
Rainier Clinical Research
Renton, Washington, United States
Start Date
April 1, 2008
Primary Completion Date
July 1, 2008
Completion Date
July 1, 2008
Last Updated
June 17, 2024
57
ACTUAL participants
FreeStyle Navigator Continuous Glucose Monitoring System Version 1.5
DEVICE
Lead Sponsor
Abbott Diabetes Care
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07480161